SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹213 Cr | ₹200 Cr | ₹178 Cr | ₹55 Cr | ₹41 Cr |
What is the latest Total Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹213 Cr |
| Mar2025 | ₹200 Cr |
| Mar2024 | ₹178 Cr |
| Mar2020 | ₹55 Cr |
| Mar2019 | ₹41 Cr |
How is Total Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹213 Cr | 6.40 | |
| Mar2025 | ₹200 Cr | 12.22 | |
| Mar2024 | ₹178 Cr | 222.38 | |
| Mar2020 | ₹55 Cr | 33.71 | |
| Mar2019 | ₹41 Cr | - | |
Compare Total Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹799.9 Cr | -4.9% | -9.9% | 21.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,265.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -4.9% |
-9.9% |
21.7% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses